Live tape
Top 8, mentions 7d6,602META1,727 mentions▲ +0.06GOOGL1,278 mentions▲ +0.03NVDA846 mentions▲ +0.09TSLA636 mentions▲ +0.05MSFT562 mentions▲ +0.06AMZN539 mentions▲ +0.04SPY527 mentions▲ +0.04AAPL487 mentions▲ +0.06

Equity · Healthcare

IBRX

NASDAQ

ImmunityBio, Inc.

$8.82 +3.16% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 29, 2026

Reddit mentioned IBRX 12 times in the 30 days to 30 September 2026, across 2 of the communities we track. All of them were scored for sentiment: 42% read bullish, 8% bearish and 50% neither. Reddit data updated 30 September 2026.

Price · Chart
Our own end-of-day closes 62 sessions
$10 $6 2 Jul 29 Sep

The line runs $9.42 on 2 July through $8.82 on 29 September, on a scale from $6 to $10. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of IBRX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 62 sessions over that window: $9.42 on 2 July 2026 through $8.82 on 29 September 2026.

Market cap $9.3B
52-week range $1.98 – $12
Avg volume 483.0K
Mentions · 30d 12
Net sentiment +0.02

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Sep 29, 2026

IBRX · crowd attention × price

Share ↗
Post on X Share on Reddit Share on LinkedIn
12 mentions

Day29 Sep 2026

MENTIONS00–6 / day
PRICE$8.82$7.5–$9.5Source: Finazon
IBRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.per day0246usd$7.5$8.0$8.5$9.0$9.51 Sep8 Sep16 Sep23 Sep30 Sep
IBRX over the last 30 days, plotting daily Reddit mentions as bars, left-hand scale; the daily closing price as a line on its own right-hand scale, solid across consecutive trading days, held flat and diagonally hatched over days the market was closed, diagonally hatched over days we hold no close for.1 Sep16 Sep30 Sep
The Distributed Sentinel 30 Sep 2026

IBRX drew 12 Reddit mentions over the 30 days to 30 September 2026

This chart in words

The chart plots daily Reddit mentions of IBRX over the 30 days to 30 September 2026: 12 in total, busiest on 30 September with 4, and 4 on the last day counted. The line is the daily close over the same window: $7.88 on 1 September, $8.82 on 29 September. Of those days, 20 were trading sessions and the other 10 are hatched on the chart. On 9 of them no session took place, and the last close before it is carried forward rather than plotted; on 1 of them we hold no close at all, which is a gap in our own record rather than a closure we can prove.

Finazon · prior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source

Crowd sentiment on IBRX · 30d

n = 12 scored · Method
IBRX

42% bullish

Overall market sentiment

55% bullish

IBRX reads 13 points less bullish than overall market sentiment. Same measure; same 30-day window.

Where IBRX is discussed

(30d)
r/wallstreetbets 83% 10 +0.00
r/stocks 17% 2 +0.11

IBRX insider trades

SEC Form 4 · last 90 days · newest reported trade 2 Jul 2026
Open-market buys 0
Open-market sells 1
Net sold $1.25M
Non-trade filings 1
Date Insider Type Shares Value
02 Jul 2026 Cohen Cheryl Director Sell 131,210 $1.25M

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Jul 2026 Cohen Cheryl Director Option exercise 55,979 $167K

IBRX reported financials

SEC EDGAR XBRL

IBRX reported revenue of $113.3M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$351.4M.

Figure Reported Period
Revenue $113.3M 31 Dec 2025 fiscal year
Net income −$351.4M 31 Dec 2025 fiscal year
Diluted EPS −$0.38 31 Dec 2025 fiscal year
Total assets $628.5M 30 Jun 2026 at period end
Total equity −$1.0B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

IBRX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-0.22 $51M
31 Mar 2026 Q1 2026 $-0.62 $44M
31 Dec 2025 FY 2025 $-0.38 $113M
30 Sep 2025 Q3 2025 $-0.07 $32M
30 Jun 2025 Q2 2025 $-0.10 $26M
31 Mar 2025 Q1 2025 $-0.15 $17M
31 Dec 2024 FY 2024 $-0.62 $15M
30 Sep 2024 Q3 2024 $-0.14 $6M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

IBRX institutional holders

SEC Form 13F

8 of the 45 institutional funds we track reported a IBRX position for the quarter ended 30 Jun 2026 — a combined $263.4M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
D. E. Shaw & Co. Held (±25%) −8.1% shares 11,551,019 $101.1M
Two Sigma Investments Added +153.0% shares 11,097,106 $97.2M
Millennium Management Added +292.9% shares 5,579,793 $48.9M
Renaissance Technologies New position 1,029,399 $9.0M
Marshall Wace Added +403.3% shares 387,700 $3.4M
AQR Capital Management Added +234.9% shares 222,862 $2.0M
Citadel Advisors Trimmed −55.5% shares 136,045 $1.2M
Balyasny Asset Management Held (±25%) −19.5% shares 83,584 $732K
Tudor Investment Corp Exited

Source: SEC EDGAR 13F filings

IBRX fails-to-deliver

SEC CNS data

On 14 Sep 2026, 3,560 shares of IBRX failed to deliver (about $28K).

Settlement date Shares failed Notional % of shares out
14 Sep 2026 3,560 $28K <0.001%
10 Sep 2026 2,942 $24K <0.001%
09 Sep 2026 2,894 $24K <0.001%
08 Sep 2026 1,109 $9K <0.001%
04 Sep 2026 3,565 $29K <0.001%
02 Sep 2026 7,977 $63K 0.001%
01 Sep 2026 150,832 $1.2M 0.014%
31 Aug 2026 1,070 $9K <0.001%
28 Aug 2026 5,233 $44K <0.001%
27 Aug 2026 43,950 $363K 0.004%
26 Aug 2026 94,511 $774K 0.009%
25 Aug 2026 47,549 $360K 0.004%
24 Aug 2026 2,098,100 $16.3M 0.198%
21 Aug 2026 21,854 $171K 0.002%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in IBRX

STOCK Act disclosures

The most recent congressional trade disclosed in IBRX is a sale by Daniel S. Goldman (house, NY), dated 06 Mar 2023.

Date Member Type Amount
06 Mar 2023 filed 17 Apr 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures

IBRX — frequently asked questions

From live data

How often is IBRX mentioned on Reddit?

IBRX was mentioned 4 times in the last 7 days across the finance subreddits we track, and 12 times over the trailing 30 days.

Is Reddit bullish or bearish on IBRX?

Across 12 classified IBRX mentions in the last 30 days, 42% read bullish, 8% bearish and 50% neutral. Crowd sentiment is a social signal, not investment advice.

When did IBRX last report earnings?

ImmunityBio (IBRX) last reported earnings on 30 Jun 2026 for Q2 2026, per SEC filings.

Are IBRX insiders buying or selling?

SEC Form 4 filings over the last 90 days show 0 buys and 1 sell by IBRX insiders on the open market. A further 1 filing was a grant, award, gift or exercise rather than an open-market trade.

What exchange is IBRX listed on?

ImmunityBio trades on NASDAQ under the ticker IBRX.

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.